Cellvax, founded in 2001, is a French SME which provides complete preclinical innovating drug validation studies both in vitro and in vivo (rodents and non-rodents) allowing to accelerate the drug development process for unmet needs related to severe human diseases, mainly in Cancer, Osteoarthritis (OA) and anti-aging fields.

Cellvax was created by a motivated and complementary team consisting of scientists and experts in these fields. By offering its know-how and its capacity of innovation,